Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Crescent Biopharma, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −2 vs. Q2 2022
- Shares held
- 25.9M
- −515.0K (−1.9%) vs. Q2 2022
- Total value
- $14.3M
- −$1.51M (−9.5%) vs. Q2 2022
- New holders
- 3
- 7 more added
- Sold out
- 5
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 282 | $0 | 0.00% | +1+0.4% | Added |
| Advisor Group Holdings, Inc. | 600 | $0 | 0.00% | 00.0% | Unchanged |
| Carolinas Wealth Consulting LLC | 395 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 200 | $0 | 0.00% | +200 | New |
| BNP Paribas Arbitrage, SA | 481 | $265 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,181 | $1.00K | 0.00% | +2,171+21,710.0% | Added |
| Hartford Financial Management Inc. | 3,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 5,063 | $3.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9,304 | $6.00K | 0.00% | 00.0% | Unchanged |
| Prentiss Smith & Co Inc | 14,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 17,262 | $10.0K | 0.00% | +17,262 | New |
| Man Group plc | 17,600 | $10.0K | 0.00% | +17,600 | New |
| Tower Research Capital LLC (TRC) | 21,577 | $12.0K | 0.00% | +12,003+125.4% | Added |
| Bank of New York Mellon Corp | 26,238 | $14.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 36,630 | $20.0K | 0.00% | −205,393−84.9% | Reduced |
| Ieq Capital, LLC | 38,363 | $21.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 43,630 | $24.0K | 0.00% | +100.0% | Added |
| Northern Trust Corp | 97,797 | $54.0K | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 100,579 | $55.5K | 0.01% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 120,500 | $66.0K | 0.02% | +32,500+36.9% | Added |
| Franklin Resources Inc | 120,671 | $67.0K | 0.00% | +1,342+1.1% | Added |
| State Street Corp | 148,965 | $82.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 155,400 | $86.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 206,900 | $114.0K | 0.00% | −110,500−34.8% | Reduced |
| Two Sigma Investments, LP | 228,303 | $126.0K | 0.00% | −93,980−29.2% | Reduced |
| Geode Capital Management, LLC | 358,395 | $197.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 366,252 | $202.0K | 0.00% | −68,403−15.7% | Reduced |
| Renaissance Technologies LLC | 526,300 | $290.0K | 0.00% | −40,100−7.1% | Reduced |
| BlackRock Inc. | 765,885 | $423.0K | 0.00% | −2,448−0.3% | Reduced |
| Vanguard Group Inc | 1,879,412 | $1.04M | 0.00% | +32,650+1.8% | Added |
| Acadian Asset Management LLC | 1,990,087 | $1.10M | 0.01% | 00.0% | Unchanged |
| NEA Management Company, LLC | 9,089,041 | $5.01M | 0.25% | 00.0% | Unchanged |
| BVF Inc | 9,544,262 | $5.27M | 0.22% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −60,353−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,618−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,154−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,796−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |